Percutaneous Treatment of Iatrogenic Femoral Artery Access Complications

Dimitrios K Tsetis, Evangelos Perdikakis, Elias Kehagias


Percutaneous minimal invasive treatment of iatrogenic femoral artery access complications (IFAACs) is considered as a first choice treatment in selected cases. Percutaneous procedures are performed under local anaesthesia, are better tolerated by the patient, and are associated with a shorter hospitalisation time, compared to open surgery. Bleeding complications can be insidious and life-threatening and prompt sealing of arterial leakage with stent-grafts or embolisation are life-saving procedures. Percutaneous US-guided thrombin injection is the treatment of choice for femoral pseudoaneurysms. The vast majority of arteriovenous fistulas (AVFs) can be treated effectively with stent-graft implantation even if the AVF is located very close to the femoral bifurcation. Catheter-directed thrombolysis assisted by subsequent prolonged balloon inflation or stent placement is able to treat effectively acute arterial thrombosis. Occasionally stenoses or occlusions provoked by percutaneous closure devices can also be managed by endovascular means.


femoral catheterisation; iatrogenic; pseudoaneurysm; dissection; arteriovenous fistula; stent graft

Full Text:



Tavris DR, Wang Y, Jacobs S, et al. Bleeding and vascular complications at the femoral access site following percutaneous coronary intervention (PCI): An evaluation of hemostasis strategies. J Invasive Cardiol 2012; 24: 328-334.

Tsetis D. Endovascular treatment of complications of femoral arterial access. Cardiovasc Intervent Radiol 2010; 33: 457-468.

Kuchulakanti PK, Satler LF, Suddath WO, et al. Vascular complications following coronary intervention correlate with long-term cardiac events. Catheter Cardiovasc Interv 2004; 62: 181-185.

Samal AK, White CJ. Percutaneous management of access site complications. Catheter Cardiovasc Interv 2002; 57: 12-23.

Merriweather N, Sulzbach-Hoke LM. Managing risk of complications at femoral vascular access sites in percutaneous coronary intervention. Crit Care Nurse 2012; 32: 16-29.

Manoukian SV. The relationship between bleeding and adverse outcomes in ACS and PCI: Pharmacologic and nonpharmacologic modification of risk. J Invasive Cardiol 2010; 22: 132-141.

Ortiz D, Jahangir A, Singh M, et al. Access site complications after peripheral vascular interventions: Incidence, predictors, and outcomes. Circ Cardiovasc Interv 2014; 7: 821-828.

Kolluri R, Fowler B, Nandish S. Vascular access complications: Diagnosis and management. Curr Treat Options Cardiovasc Med 2013; 15: 173-187.

Mehran R, Rao SV, Bhatt DL, et al. Standardized bleeding definitions for cardiovascular clinical trials: A consensus report from the Bleeding Academic Research Consortium. Circulation 2011; 123: 2736-2747.

Patel NH, Krishnamurthy VN, Kim S, et al. CIRSE and SIR Standards of Practice Committees. Quality improvement guidelines for percutaneous management of acute lower-extremity ischemia. J Vasc Interv Radiol. 2013; 24: 3-15.

Thore V, Berder V, Houplon P, et al. Role of manual compression time and bed rest duration on the occurrence of femoral bleeding complications after sheath retrieval following 4Fr left sided cardiac catheterization. J Interv Cardiol 2001; 14: 7-10.

Rao SV, McCoy LA, Spertus JA, et al. An updated bleeding model to predict the risk of post-procedure bleeding among patients undergoing percutaneous coronary intervention: A report using an expanded bleeding definition from the National Cardiovascular Data Registry CathPCI Registry. JACC Cardiovasc Interv 2013; 6: 897-904.

Baumann F, Husmann M, Benenati JF, et al. Bleeding Risk Profile in Patients With Symptomatic Peripheral Artery Disease. J Endovasc Ther 2016; 23: 468-471.

Tagney J, Lackie D. Bed-rest post femoral arterial sheath removal: What is safe practice? A clinical audit. Nurs Crit Care 2005; 10: 167-173.

Eggebrecht H, Naber C, Woertgen U, et al. Percutaneous suture-mediated closure of femoral access sites deployed through the procedure sheath: Initial clinical experience with a novel vascular closure device. Cath Cardiovasc Int 2003; 58: 313-321.

Doyle BJ, Ting HH, Bell MR, et al. Major femoral bleeding complications after percutaneous coronary intervention: Incidence, predictors, and impact on long-term survival among 17,901 patients treated at the Mayo Clinic from 1994 to 2005. JACC Cardiovasc Interv 2008; 1: 202-209.

Novelli M, Righi D, Pilato A. Color Doppler evaluation and diagnosis of local complications after arterial endovascular procedures. Recenti Prog Med 2012; 103: 337-347.

Fleischmann D, Lammer J. Peripheral CT angiography for interventional treatment planning. Eur Radiol 2006; 16 Suppl 7: M58-64.

Lopera JE, Trimmer CK, Josephs SG, et al. Multidetector CT angiography of infrainguinal arterial bypass. Radiographics 2008; 28: 529-548.

Stone PA, Campbell JE. Complications related to femoral artery access for transcatheter procedures. Vasc Endovascular Surg 2012; 46: 617-623.

Yaganti V, Mejevoi N, Hasan O, et al. Pitfalls associated with the use of current recommendations for fluoroscopy-guided common femoral artery access. Catheter Cardiovasc Interv 2013; 81: 674-679.

Castillo-Sang M, Tsang AW, Almaroof B, et al. Femoral artery complications after cardiac catheterization: A study of patient profile. Ann Vasc Surg 2010; 24: 328-335.

Calligaro KD, Balraj P, Moudgill N, et al. Results of polytetrafluoroethylene-covered nitinol stents crossing the inguinal ligament. J Vasc Surg 2013; 57: 421-426.

Donas KP, Torsello GF. Endovascular surgery as a bridge solution for selected vascular emergencies. J Cardiovasc Surg (Torino) 2010; 51: 337-342.

Shannon J, Latib A, Colombo A. Iatrogenic perforation of the medial circumflex artery following femoral venous cannulation for transcatheter aortic valve replacement, presenting with retroperitoneal hematoma and successfully managed by percutaneous embolization and coiling. Catheter Cardiovasc Interv 2012; 80: 1002-1006.

Maleux G, Hendrickx S, Vaninbroukx J, et al. Percutaneous injection of human thrombin to treat iatrogenic femoral pseudoaneurysms: Short- and midterm ultrasound follow-up. Eur Radiol 2003; 13: 209-212.

Khoury M, Rebecca A, Greene K, et al. Duplex scanning guided thrombin injection for the treatment of iatrogenic pseudoaneurysms. J Vasc Surg 2002; 35: 517-521.

La Perna L, Olin JW, Goines D, et al. Ultrasound-guided thrombin injection for the treatment of postcatheterization pseudoaneurysms. Circulation 2000; 102: 2391-2395.

Matson MB, Morgan RA, Belli AM. Percutaneous treatment of pseudoaneurysms using fibrin adhesive. Br J Radiol 2001; 74: 690-694.

Owen RJT, Haslam PJ, Elliott ST, et al. Percutaneous ablation of peripheral pseudoaneurysms using thrombin: A simple and effective solution. CardioVasc Interv Radiol 2000; 23: 441-446.

Elford J, Burrell C, Freeman S, et al. Human thrombin injection for the percutaneous treatment of iatrogenic pseudoaneurysms. Cardio Vasc Interv Radiol 2002; 25: 115-118.

Périard D, Rey Meyer MA, Hayoz D, et al. Sealing pseudo-aneurysms of the femoral artery with saline injection: A new technique. EuroIntervention 2012; 7(10): 1206-1209.

Thalhammer C, Kirchherr AS, Uhlich F, et al. Postcatheterization pseudoaneurysms and arteriovenous fistulas: Repair with percutaneous implantation of endovascular covered stents. Radiology 2000; 214: 127-131.

Baltacioglu F, Cim NC, Cil B, et al. Endovascular stent-graft applications in iatrogenic vascular injuries. CardioVasc Interv Radiol 2003; 26: 434-439.

Rathod JR, Dhomne S, Taori K, et al. Endovascular stent graft for post-traumatic superficial femoral artery pseudoaneurysms with arteriovenous fistula: 6 months follow-up of 2 cases. J Radiol Case Rep 2011; 5: 26-34.

Onal B, Ilgit ET, Koşar S, et al. Endovascular treatment of peripheral vascular lesions with stent-grafts. Diagn Interv Radiol 2005; 11: 170-174.

Tsetis DK, Kochiadakis GE, Hatzidakis AA, et al. Transcatheter thrombolysis with high-dose bolus tissue plasminogen activator in iatrogenic arterial occlusion after femoral arterial catheterization. CardioVasc Interv Radiol 2002; 25: 36-41.

Liu Q, Yan CW, Zhao SH, et al. Thrombolytic therapy for femoral artery thrombosis after left cardiac catheterization in children. Chin Med J (Engl) 2009; 122: 931-934.

Hon LQ, Ganeshan A, Thomas SM, et al. An overview of vascular closure devices: What every radiologist should know. Eur J Radiol 2010; 73: 181-190.

Bangalore S, Arora N, Resnic FS. Vascular closure device failure: Frequency and implications: A propensity-matched analysis. Circ Cardiovasc Interv 2009; 2: 549-556.

Kim YJ, Yoon HK, Ko GY, et al. Percutaneous transluminal angioplasty of suture-mediated closure device-related femoral artery stenosis or occlusive disease. Br J Radiol 2009; 82: 486-490.

Steinkamp HJ, Werk M, Beck A, et al. Excimer laser-assisted recanalisation of femoral arterial stenosis or occlusion caused by the use of Angio-Seal. Eur Radiol 2001; 11: 1364-1370.

Lee JH, Biring TS, Gimelli G. Treatment of an Angio-Seal-related vascular complication using the SilverHawk plaque excision system: A case report. Cath Cardiovasc Interv 2007; 69: 141-145.

Ratnam LA, Raja J, Munneke GJ, et al. Prospective nonrandomized trial of manual compression and Angio-Seal and Starclose arterial closure devices in common femoral punctures. CardioVasc Interv Radiol 2007; 30: 182-188.

Gonsalves M, Walkden M, Belli AM. Laceration of the common femoral artery following deployment of the starclose vascular closure system. CardioVasc Interv Radiol 2008; 31: 817-820.


  • There are currently no refbacks.